Arca
Skip to content
Tools
Tools

Biosaca System, Model 800

Standard Polysomnograph With Electroencephalograph. 510(k) K991446, from Biosys AB (Publ) (Chester, NY). Product code OLV, class 2.

As of Nov 18, 2026, K991446 is an FDA 510(k) held by Biosys AB (Publ), substantially equivalent on Jul 23, 1999 after 88 days, with no recalls tied to it in FDA's recall database.

  • Review time: 88 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The BIOSACA equipment is indicated for use in the recording, displaying, monitoring, printing and storage of human bioparameters such as brain, heart and muscle activity, eye movement, breathing and body movements.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF
  • Biosaca SystemK984580 · Biosys AB (Publ) · Mar 12, 1999
  • EmblaK971813 · Ferguson Medical · Jan 16, 1998

Other OLV clearances

The newest 510(k)s for the same product code; their median review was 230 days; see every OLV device

Record

Type
Traditional
Received
Apr 26, 1999
Review panel
Neurology
Regulation
21 CFR 882.1400

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.